CompletedNot Applicable

Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents

United States27 participantsStarted 2009-12

Plain-language summary

This protocol matches child subjects with peer mentors of similar age who have learned to function successfully with a chronic pain disorder. The trained mentors will present information to the subjects in a supervised and monitored interaction via telephone and computer for 2 months and encourage participation in skill-building programs. Children will be tested for improvement in pain and functioning at 2 months and again at 4 months to see if improvements persist. The investigators hypothesize that children who received peer mentor support will show more improvement in pain and functioning at 2 and 4 months into treatment than those in a control group who do not receive mentor support.

Who can participate

Age range

12 Years – 18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Mentors Inclusion criteria: * between the ages of 14 and 18 * any patient who has been successfully treated in the UCLA Pediatric Pain Program * access to telephone * access to internet enabled computer Exclusion criteria * younger than 14 * older than 18 * new patient * no access to telephone * no access to internet enabled computer Mentees and controls: Inclusion Criteria: * chronic pain diagnosis * between the ages of 12 and 17 * access to telephone * access to internet enabled computer * new to UCLA Pediatric Pain Clinic * plans to utilize program CAM therapies Exclusion Criteria: * already utilizing UCLA Pediatric Pain Program CAM therapies * unable to read, speak, or understand english * younger than 12 or older than 17 * no access to telephone * no access to internet enabled computer * not new patient to UCLA Pediatric Pain Clinic * does not plan to utilize program CAM therapies

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Adherence to Physician Recommended CAM Therapies

Timeframe: post intervention (week 8)

Trial details

NCT IDNCT01118988

SponsorUniversity of California, Los Angeles

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2011-06

Results submitted2016-02-10

View on ClinicalTrials.gov More Irritable Bowel Syndrome (IBS) trials